BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27082996)

  • 21. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
    Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
    J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
    Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
    EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating the Role of the Maternal Embryonic Leucine Zipper Kinase in Adrenocortical Carcinoma.
    Kiseljak-Vassiliades K; Zhang Y; Kar A; Razzaghi R; Xu M; Gowan K; Raeburn CD; Albuja-Cruz M; Jones KL; Somerset H; Fishbein L; Leong S; Wierman ME
    Endocrinology; 2018 Jul; 159(7):2532-2544. PubMed ID: 29790920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma.
    Bolomsky A; Heusschen R; Schlangen K; Stangelberger K; Muller J; Schreiner W; Zojer N; Caers J; Ludwig H
    Haematologica; 2018 Feb; 103(2):325-335. PubMed ID: 29122991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching of INCENP paralogs controls transitions in mitotic chromosomal passenger complex functions.
    Feng H; Raasholm M; Moosmann A; Campsteijn C; Thompson EM
    Cell Cycle; 2019 Sep; 18(17):2006-2025. PubMed ID: 31306061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Centromere localization of INCENP-Aurora B is sufficient to support spindle checkpoint function.
    Becker M; Stolz A; Ertych N; Bastians H
    Cell Cycle; 2010 Apr; 9(7):1360-72. PubMed ID: 20372054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases.
    Marxer M; Ma HT; Man WY; Poon RY
    Oncogene; 2014 Jul; 33(27):3550-60. PubMed ID: 23955083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.
    Chung S; Suzuki H; Miyamoto T; Takamatsu N; Tatsuguchi A; Ueda K; Kijima K; Nakamura Y; Matsuo Y
    Oncotarget; 2012 Dec; 3(12):1629-40. PubMed ID: 23283305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatase 1 Nuclear Targeting Subunit (PNUTS) Regulates Aurora Kinases and Mitotic Progression.
    Wang F; Wang L; Fisher LA; Li C; Wang W; Peng A
    Mol Cancer Res; 2019 Jan; 17(1):10-19. PubMed ID: 30190438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Borealin dimerization mediates optimal CPC checkpoint function by enhancing localization to centromeres and kinetochores.
    Bekier ME; Mazur T; Rashid MS; Taylor WR
    Nat Commun; 2015 Apr; 6():6775. PubMed ID: 25854549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
    Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
    Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centromere-localized Aurora B kinase is required for the fidelity of chromosome segregation.
    Liang C; Zhang Z; Chen Q; Yan H; Zhang M; Zhou L; Xu J; Lu W; Wang F
    J Cell Biol; 2020 Feb; 219(2):. PubMed ID: 31868888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SUMOylation of DNA topoisomerase IIα regulates histone H3 kinase Haspin and H3 phosphorylation in mitosis.
    Yoshida MM; Ting L; Gygi SP; Azuma Y
    J Cell Biol; 2016 Jun; 213(6):665-78. PubMed ID: 27325792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aurora B defines its own chromosomal targeting by opposing the recruitment of the phosphatase scaffold Repo-Man.
    Qian J; Beullens M; Lesage B; Bollen M
    Curr Biol; 2013 Jun; 23(12):1136-43. PubMed ID: 23746640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
    Chung S; Kijima K; Kudo A; Fujisawa Y; Harada Y; Taira A; Takamatsu N; Miyamoto T; Matsuo Y; Nakamura Y
    Oncotarget; 2016 Apr; 7(14):18171-82. PubMed ID: 26918358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two histone marks establish the inner centromere and chromosome bi-orientation.
    Yamagishi Y; Honda T; Tanno Y; Watanabe Y
    Science; 2010 Oct; 330(6001):239-43. PubMed ID: 20929775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual recognition of chromatin and microtubules by INCENP is important for mitotic progression.
    Wheelock MS; Wynne DJ; Tseng BS; Funabiki H
    J Cell Biol; 2017 Apr; 216(4):925-941. PubMed ID: 28314740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Bub1-Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation.
    Jia L; Li B; Yu H
    Nat Commun; 2016 Feb; 7():10818. PubMed ID: 26912231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283.
    Curry J; Angove H; Fazal L; Lyons J; Reule M; Thompson N; Wallis N
    Cell Cycle; 2009 Jun; 8(12):1921-9. PubMed ID: 19440047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis.
    Tang B; Zhu J; Fang S; Wang Y; Vinothkumar R; Li M; Weng Q; Zheng L; Yang Y; Qiu R; Xu M; Zhao Z; Ji J
    Free Radic Biol Med; 2021 Aug; 172():312-329. PubMed ID: 34144192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.